Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates. (Q48085025)

8 February 2018

title

Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates. (English)

1 reference

8 February 2018

4

Ronald Swanstrom

1 reference

8 February 2018

5

Lynn Morris

1 reference

8 February 2018

Mia Coetzer

1

1 reference

8 February 2018

Tonie Cilliers

series ordinal

2

1 reference

8 February 2018

Li-Hua Ping

series ordinal

3

1 reference

8 February 2018

language of work or name

English

0 references

publication date

30 August 2006

1 reference

8 February 2018

published in

Virology

1 reference

8 February 2018

volume

356

1 reference

8 February 2018

page(s)

95-105

1 reference

8 February 2018

issue

1-2

1 reference

8 February 2018

HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

HIV type 1 envelope subtype C sequences from recent seroconverters in Zimbabwe.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

A new classification for HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Genotypic and phenotypic characterization of viral isolates from HIV-1 subtype C-infected children with slow and rapid disease progression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Sensitivity of HIV type 1 subtype C isolates to the entry inhibitor T-20.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Change in coreceptor use correlates with disease progression in HIV-1--infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

The crown and stem of the V3 loop play distinct roles in human immunodeficiency virus type 1 envelope glycoprotein interactions with the CCR5 coreceptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Identification of a major co-receptor for primary isolates of HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

7 January 2021

V3: HIV's switch-hitter

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Variability in the human immunodeficiency virus type 1 gp120 Env protein linked to phenotype-associated changes in the V3 loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Identification of ENV determinants in V3 that influence the molecular anatomy of CCR5 utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Structure of a V3-containing HIV-1 gp120 core

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

High frequency of syncytium-inducing and CXCR4-tropic viruses among human immunodeficiency virus type 1 subtype C-infected patients receiving antiretroviral treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Relationship of human immunodeficiency virus type 1 sequence heterogeneity to stage of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Intrapatient alterations in the human immunodeficiency virus type 1 gp120 V1V2 and V3 regions differentially modulate coreceptor usage, virus inhibition by CC/CXC chemokines, soluble CD4, and the b12 and 2G12 monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Intrinsic obstacles to human immunodeficiency virus type 1 coreceptor switching

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Changes in and discrepancies between cell tropisms and coreceptor uses of human immunodeficiency virus type 1 induced by single point mutations at the V3 tip of the env protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Small amino acid changes in the V3 hypervariable region of gp120 can affect the T-cell-line and macrophage tropism of human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Effect of amino acid substitution of the V3 and bridging sheet residues in human immunodeficiency virus type 1 subtype C gp120 on CCR5 utilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Fold recognition of the human immunodeficiency virus type 1 V3 loop and flexibility of its crown structure during the course of adaptation to a host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Characterization and selection of HIV-1 subtype C isolates for use in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

inferred from DOI database lookup

7 January 2021

based on heuristic

Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

inferred from DOI database lookup

7 January 2021

based on heuristic

Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.07.030

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.07.030

1 reference

8 February 2018

PubMed ID

16942785

1 reference

8 February 2018